Impact of Centres With Different Patient Volume on Diagnostic Process, Therapeutic Strategy and Outcome in Patients With Localised Rhabdomyosarcoma: A Report From the European paediatric Soft tissue sarcoma Study Group (EpSSG) Maria Carmen Affinita, Maja Cesen, Peter Mudry, Christine Devalck, Heide Glosli, Beatrice Coppadoro, Ilaria Zanetti, Veronique Minard‐Colin, Julia C. Chisholm, Daniel Orbach, Sheila Terwisscha van Scheltinga, Raquel Davila Fajardo, Lise Borgwardt, Johannes H. M Merks, Gianni Bisogno Pediatric Blood and Cancer, 2026 Introduction We examined the impact of the treatment centre volumes (number of patients per centre) on the management and outcomes of rhabdomyosarcoma (RMS) patients enrolled. Methods We analysed 1613 patients with localised RMS treated from 2005 to 2016 in 126 European centres classified as high‐, medium‐, or low‐volume according to the number of patients enrolled in the RMS 2005 protocol coordinated by the European paediatric Soft tissue sarcoma Study Group (E p SSG). We evaluated diagnostic and treatment indicators, protocol adherence and survival outcomes. Result Patients’ demographic and tumour characteristics were overall comparable across groups, though high‐volume centres treated more patients with advanced disease. Diagnostic work‐up largely adhered to protocol recommendations, with minor differences: high‐volume centres showed greater adherence to central pathology review (77.7%) and molecular testing (76.2%), while medium‐volume centres used 18 FDG‐PET/CT more frequently (39.7%). Risk group misclassification occurred in 4.5% of patients, more often in low‐volume centres. Other treatment quality indicators, including surgical margins, chemotherapy adherence, radiotherapy administration, and participation in the randomised trials, were comparable among groups. Five‐year event‐free survival and overall survival did not differ significantly between groups, including high‐risk subgroups. Conclusion In the treatment of paediatric RMS, adherence to standardised treatment protocols ensures consistent outcomes across centres of varying volumes. Observed differences in specific diagnostic processes highlight the importance of fostering international collaboration and drawing on the expertise of high‐volume centres to enhance the quality of care and outcomes for paediatric RMS patients. The adoption of a standardised international protocol would help standardise care and outcomes across Europe, thereby minimising geographical disparities and ensuring equitable access to high‐quality treatment.
Who leads, who treats, what dose? European paediatric differentiated thyroid carcinoma practice-an European Cooperative Study Group for Paediatric Rare Tumours survey Michaela Kuhlen, Jelena Roganivic, Samuele Naviglio, Fredrik Baecklund, Rachel Bello, Tal Ben-Ami, Luca Bergamaschi, Ernest Bilic, Ewa Bien, Manuel João Brito, Alicia Castañeda, Maja Cesen Mazic, Nuno Jorge dos Reis Farinha, Aleksandra Jovanovska, Ronald de Krijger, Maria Debora de Pasquale, Rossella Elisei, Gema Grau Bolado, Gabriela Guillén, Magalie Haissaguerre, Dana Hartl, Jorge Huerta-Aragonés, Malgorzata A Krawczyk, Livia Lamartina, Filipa Leite, Valeriano Leite, Ricardo López Almaraz, Nevena Manevska, Ludovic Mansuy, Evelina Miele, Elin Hallan Naderi, Thilde Nordmann Winther, Isabelle Oliver Petit, Zeynep Alev Özön, Marta Giorgia Podda, Apostolos Pourtsidis, Yves Reguerre, Maria Sandström, Dominik T Schneider, Saniye Ekinci, Jasna Suput Omladic, Beata Sztangierska, Cecile Verite, Nicolas Waespe, Kee Howe Wong, Bilgehan Yalcin, Michael Abele, Gianni Bisogno, Daniel Orbach, Ines B Brecht, Calogero Virgone, Antje Redlich European Journal of Endocrinology, 2026 Objective To map real-world management of paediatric differentiated thyroid carcinoma (DTC) across Europe and identify targets for harmonization. Design Cross-sectional, web-based survey of centres providing paediatric DTC care. Setting & Participants One consolidated response per centre was requested from a clinician overseeing paediatric DTC. The instrument covered centre profile/multidisciplinary tumour (MDT) board organization; staging and guideline use; risk stratification and dynamic response; diagnostics; surgery/lymph node management; radioactive iodine therapy (RAIT) policy and activity selection; and thyroid-stimulating hormone targets, follow-up, shared-care/transition. Analyses were descriptive at centre level. Results Forty-two centres from 18 countries participated in the survey. Response denominators varied by item. Among responding centres, ≈75% were university or academic hospitals, ≈70% used a paediatric age cut-off of ≤18 years, and ≈60% reported having a dedicated MDT board. Staging and guideline use were heterogeneous: centres most often reported mixed or centre-specific guidance, followed by the American Thyroid Association (ATA) 2015 guideline, national guidelines, and the European Thyroid Association (ETA) 2022 guideline. Dynamic response-to-therapy categories were commonly used. For unilateral presumed low-risk disease, hemithyroidectomy was the usual initial surgery in approximately two-thirds to three-quarters of centres, whereas total thyroidectomy was less common. For low-risk patients, RAIT policy were split between de-escalation and risk-adapted use. When administered, RAIT activity was determined using weight-based, dosimetric, or fixed empirical approaches. Country-level patterns suggested clustering around ETA-leaning, ATA-leaning, and national guideline frameworks. Conclusions Across Europe, centres broadly endorse risk-adapted care but diverge at key decision nodes—extent of surgery, formal risk framework, and RAIT in low-risk disease—reflecting guidance plurality and organizational context. Leveraging existing infrastructures offers pragmatic avenues to reduce unwarranted variation while generating paediatric-specific evidence to refine recommendations.
Expecting the unexpected: diagnostic imaging of side effects due to cancer treatment in children Anna Michielin, Giulia Fichera, Monica Zuliani, Francesco Causin, Diego Cecchin, Francesca Serani, Alessandro di Paola, Pietro Zucchetta, Marta Pillon, Gianni Bisogno, Roberto Stramare, Chiara Giraudo Clinical and Translational Imaging, 2026 Pediatric oncological treatments significantly improved in the last decades with a significant positive impact on survival rates. Despite these achievements, cancer therapy is affected by side effects which may represent a diagnostic challenge and influence the overall management of children with tumors. Diagnostic imaging plays a crucial role in diagnosing adverse events, distinguishing them also from potential mimickers like infections or recurrences. Radiologists and nuclear medicine physicians are expected to have a deep knowledge of the common therapeutic schemes, their potential side effects, and features at imaging. Therefore, the aim of this review is to provide a comprehensive overview of the role of imaging, including hybrid techniques, in correctly identifying and characterizing the side effects of cancer treatment in children, including a brief overview of the main therapeutic options in pediatric oncology.
Children and Young People With First Relapse or Progression of Upfront Metastatic Rhabdomyosarcoma: An Analysis of Clinical Features and Outcomes From the INternational Soft Tissue saRcoma ConsorTium (INSTRuCT) Ajla T. Wasti, Gianni Bisogno, Beatrice Coppadoro, Ilaria Zanetti, Martin Ebinger, Amadeus T. Heinz, Henry C. Mandeville, Rita Alaggio, Michela Casanova, Sheila E. J. Terwisscha van Scheltinga, Rick R. van Rijn, Veronique Minard‐Colin, Daniel Orbach, Natalie B. Collins, Wei Xue, Rajkumar Venkatramani, Johannes H. M. Merks, Julia C. Chisholm Cancer Medicine, 2026 Introduction We evaluated the survival rate/survivor characteristics following first progression/relapse of metastatic rhabdomyosarcoma (M1 RMS), using pooled European and US collaborative group data from the INternational Soft Tissue saRcoma ConsorTium (INSTRuCT). Methods Patients with first diagnosis of M1 RMS aged 0–40 years were identified within the INSTRuCT database (Upfront Cohort; UC). The First Event Cohort (FEC) included UC patients with first event of disease progression/relapse. Clinical features and survival of FEC patients were described. Results UC included 1095 eligible M1 RMS patients. 5‐year Overall and Event Free Survival were 32.0% (95% Confidence Interval (CI) 29.2–34.9) and 27.5% (95% CI 24.8–30.2) respectively. Median time to event was 13.9 months (range 1 day‐172.6 months). Among UC patients, 727 with first event of progression/relapse were included in FEC. 3‐year Overall Survival for FEC from first event was 8.0% (95% CI 6.1–10.2). Thirty‐four (4.7%) FEC patients were alive with > 3 years follow up (“disease free”) and 16 (2.2%) with < 3 years follow up. FEC patients alive > 3 years were significantly more likely than deceased FEC patients to have: younger age ( p = 0.0031); no locoregional lymph node involvement ( p = 0.0013); fewer metastatic sites ( p = 0.006); no bone and/or bone marrow disease ( p < 0.001 for each); lower Oberlin scores ( p < 0.0001); time to first event > 18 months ( p < 0.0001). Univariate and multivariable analyses conducted in FEC to investigate factors impacting OS showed that Oberlin score ≥ 2 (Hazard Ratio (HR) 1.295, 95% Confidence Limits (CL) 1.07–1.57, p = 0.0074) and involvement of loco‐regional lymph nodes at diagnosis (HR 1.28, 95% CL 1.08–1.52, p = 0.0053) were associated with worse outcome. Conclusions Outcomes following first progression/relapse of M1 RMS are dismal. Survivors had fewer adverse prognostic features at first presentation and later first events. Further work is required to predict survivors of first relapse more reliably.
Characteristics and Outcome of Patients With Refractory Orbital Rhabdomyosarcoma Gianni Bisogno, Maria Carmen Affinita, Giuseppe Maria Milano, Ilaria Zanetti, Elena Poli, Francesco De Leonardis, Katia Perruccio, Rita Alaggio, Stefano Chiaravalli, Virginia Livellara, Giovanni Scarzello, Andrea Ferrari Head and Neck, 2026 Background Orbital rhabdomyosarcoma (oRMS) is a rare pediatric soft‐tissue sarcoma with generally excellent outcomes; however, a subset of patients relapse, and evidence on optimal salvage strategies and long‐term survival after recurrence remains limited. Methods Pediatric patients with oRMS enrolled in the cooperative protocols RMS79, RMS88, RMS96, and RMS2005 between 1979 and 2016. Results Among 117 enrolled patients, 30 relapsed, predominantly with local recurrence. Relapse was associated with age < 1 year, female sex, RMS88 protocol, incomplete initial surgery, and omission of radiotherapy. Salvage treatments included multi‐agent chemotherapy, radiotherapy, and surgery, with orbit exenteration performed in a total of 13 cases. After a median follow‐up of 12.7 years from relapse, 10‐year OS and EFS were 56.0% and 43.3%, respectively. Conclusions Although oRMS usually has an excellent prognosis, relapse remains challenging. Multidisciplinary salvage therapy can yield long‐term survival in over half of relapsed patients. Better initial treatment selection is needed to reduce relapse and late toxicity.
Diagnostic Delay and Survival in Pediatric Rhabdomyosarcoma: Is Time a Critical Factor? Maria C. Affinita, Stefano Chiaravalli, Giuseppe M. Milano, Ida Russo, Katia Perruccio, Ariana Tagarelli, Patrizia Bertolini, Carla Manzitti, Federico Mercolini, Angela Tamburini, Francesco De Leonardis, Paolo D’Angelo, Stefania Cardellicchio, Andrea Di Cataldo, Daniela Di Pinto, Rosa Maria Mura, Beatrice Coppadoro, Andrea Ferrari, Gianni Bisogno Journal of Pediatric Hematology Oncology, 2026 Background: Timely diagnosis is considered critical in pediatric oncology to optimize treatment outcomes, as delays may impact tumor extension and prognosis. We aimed to assess whether the time to diagnosis and treatment initiation for pediatric patients with rhabdomyosarcoma (RMS) improved over time in Italy and whether longer delays were associated with tumor extension and prognosis. Methods: We analyzed 749 pediatric patients diagnosed with RMS between 1996 and 2016. Diagnostic interval (DI) was defined as the number of days from symptom onset to diagnosis, while treatment interval (TI) was defined as the time from symptom onset to treatment initiation. DI was correlated with tumor characteristics at diagnosis, and TI was analyzed in relation to survival, using Kaplan-Meier analysis. Results: The median DI was 32 days, showing a decreasing trend from 39.5 days in 1996 to 2000 to 30 days in 2011 to 2016. A longer DI was associated with age, unfavorable histology, and metastatic disease in univariate analysis, but these were not confirmed in multivariate analysis. The median TI was 48 days. Five-year event-free survival (EFS) and overall survival (OS) were 59.7% and 69.3%. In multivariate analysis, prognosis was negatively associated with age at diagnosis, unfavorable site, nodal involvement, and metastatic disease. TI was not associated with survival. Conclusions: In our national cohort, the time from symptom onset to diagnosis showed a trend toward shortening in recent years. While a timely diagnosis can provide clarity on the child’s condition and potentially reduce parental anxiety, it does not substantially impact tumor characteristics or patient outcomes.
Carcinomas and Carcinoid Tumors of the Lungs and Bronchi in Children and Adolescents: The EXPeRT Recommendations Michael Abele, Calogero Virgone, Michaela Kuhlen, Sabine Irtan, Yves Reguerre, Malgorzata Krawczyk, Ewa Bien, Tal Ben‐Ami, Maja Cesen, Ricardo Lopez‐Almaraz, Andrea Ferrari, Gianni Bisogno, Dominik T. Schneider, Abbas Agaimy, Constantin Lapa, Hubert Ducou le Pointe, Rainer Claus, Catherine Daniel, Ines B. Brecht, Daniel Orbach Pediatric Blood and Cancer, 2026 Primary lung carcinomas and bronchial carcinoid tumors (BC) are very rare malignancies in childhood. While typical BC and mucoepidermoid carcinomas are mostly low‐grade, localized tumors with a more favorable prognosis than in adults, necessitating avoidance of overtreatment, adenocarcinomas of the lung are often diagnosed at advanced disease stages with low survival rates. This paper presents consensus recommendations on the diagnosis and treatment of pediatric patients with primary lung carcinomas and BC, established by the European Cooperative Study Group for Pediatric Rare Tumors ( EXPeRT ) in collaboration with the European Reference Network for Pediatric Oncology (ERN PaedCan).
European Standard Clinical Practice Guideline and EXPeRT Recommendations for the Diagnosis and Management of Gastroenteropancreatic Neuroendocrine Neoplasms in Children and Adolescents Michaela Kuhlen, Calogero Virgone, Antje Redlich, Michael Abele, Ricardo Lopez‐Almaraz, Tal Ben‐Ami, Ewa Bien, Gianni Bisogno, Maja Mazic Cesen, Andrea Ferrari, Malgorzata A. Krawczyk, Yves Reguerre, Dominik T. Schneider, Ines B. Brecht, Charlotte Rigaud, Bilgehan Yalcin, Rainer Claus, Christian Vokuhl, Constantin Lapa, Jörg Fuchs, Segolene Hescot, Thomas Walter, Julien Hadoux, Daniel Orbach Pediatric Blood and Cancer, 2026 Pediatric gastroenteropancreatic neuroendocrine neoplasms (GEP‐NENs) are extremely rare and clinically heterogeneous. Management has largely been extrapolated from adult practice. This European Standard Clinical Practice Guideline (ESCP), developed by the EXPeRT network in collaboration with adult NEN experts, provides (adult) evidence‐informed and consensus‐driven recommendations. Using a literature review and GRADE methodology, we address clinical evaluation, imaging pathology, genetics, surgical and systemic therapies, and long‐term surveillance. Surgical resection is the cornerstone in localized disease. Systemic treatments are largely adapted from adult data, including somatostatin analogues, radiopharmaceutical therapy, and targeted agents. Multidisciplinary care, genetic counseling, and lifelong follow‐up are essential to optimize outcomes.
Surgical nodal staging in rhabdomyosarcoma of the bladder and/or prostate with or without nodal or metastatic spread. A report from the European Paediatric Soft-Tissue Sarcoma Study Group (EpSSG) Naima Smeulders, Mark N. Gaze, Florent Guérin, Timothy Rogers, Sheila Terwisscha van Scheltinga, Federica DeCorti, Julia Chisholm, Olga Slater, Veronique Minard-Colin, Beatrice Coppadoro, Ilaria Zanetti, Ross Craigie, Gabriela Guillén Burrieza, Patrizia Dall’Igna, Raquel Dávila Fajardo, Pei Lim, Cyrus Chargari, Sophie Espenel, Ana L. Luis Huertas, Alexander Cho, Trung Nguyen, Helen Rees, Gianni Bisogno, Johannes H.M. Merks, Hélène Martelli Journal of Pediatric Surgery, 2026 BACKGROUND: Risk stratification of rhabdomyosarcoma (RMS) requires accurate staging, with histological nodal assessment being of critical importance for specific tumour sites. This report explores the value of surgical nodal staging in bladder-prostate rhabdomyosarcoma (BP-RMS). PROCEDURE: Patients with BP-RMS enrolled in the RMS2005 and MTS2008 trials (2005-2016) were reviewed for the staging methodology and outcome. RESULTS: Significant differences in 5-year overall and progression-free survival were observed for the 224 patients with BP-RMS of different Tumour-Node-Metastasis (TNM) stages (p < 0.0001). Nodal staging was by imaging in all but 7/224 (3.1%) patients at presentation. Despite the opportunity for nodal sampling at surgery in 175 patients, no nodes were obtained in 120/175 (68.6%). Nodal sampling at surgery after 4-8 chemotherapy cycles in 48 patients, identified tumour in 6/37 (16.2%) patients considered N0 by imaging (all aged <10 years with favourable histology >5 cm tumours) and observed no tumour in 8/11 (72.7%) deemed N1, prompting changes to local therapy in 9/14 (64.3%). Overall, surgical nodal assessment did not impact on local/nodal progression/relapse (12/55, 21.8%) as compared to staging by imaging alone (29/166, 16.9%, p = 0.548; data missing for 3 patients). Pathological nodal assessment also failed to show benefit on locoregional events for patients with significantly poorer outcome, namely those aged ≥10 years (p = 0.446) or with unfavourable histology (p = 0.613). The specific targeting of nodal basins by radiotherapy showed no impact on outcome (p = 1.000). CONCLUSIONS: In contrast to other sites, surgical nodal sampling, undertaken in 24.6% (in 3.1% at diagnosis), does not significantly impact outcome of BP-RMS, despite imaging-pathological discordance prompting changes to treatment for affected patients.
Melanomas and Mesenchymal Tumors Arising in Giant Congenital Melanocytic Nevi: Clinico-Pathological and Molecular Characterization of a Case Series Sabrina Rossi, Sabina Barresi, Isabella Giovannoni, Silvia Genovese, Valentino Costabile, Alessandra Stracuzzi, Silvia Vallese, Chantal Tancredi, Andrea Diociaiuti, Giuseppe M. Milano, Andrea Ferrari, Patrizia Bertolini, Stefano Chiaravalli, Emanuele Agolini, Gemma D'Elia, Giorgia Catino, Licia Martucci, Marta Cajozzo, Fabio Dell'Otto, Gianni Bisogno, Alessandro Crocoli, Evelina Miele, Giovanna Zambruno, Maria Debora De Pasquale, Mario Zama, Antonio Novelli, May El Hachem, Viola Alesi, Rita Alaggio Pigment Cell and Melanoma Research, 2026
Childhood, Adolescent and Young Adult Poor-Prognosis Rhabdomyosarcoma Ajla T. Wasti, Gianni Bisogno, Raquel Hladun, Anne-Sophie Defachelles, Michela Casanova, Willemijn B. Breunis, Susanne A. Gatz, Reineke A. Schoot, Andrea Ferrari, Meriel Jenney, Rita Alaggio, Raquel Davila Fajardo, Sheila Terwisscha van Scheltinga, Janet Shipley, Michael Torsten Meister, Rick R. van Rijn, John Anderson, Monika Sparber-Sauer, Julia C. Chisholm, Johannes H. M. Merks Cancers, 2025
Is There a Role for Mifamurtide in Nonmetastatic High-Grade Osteosarcoma? Results From the Italian Sarcoma Group (ISG/OS-2) and Spanish Sarcoma Group (GEIS-33) Trials Emanuela Palmerini, Cristina Meazza, Angela Tamburini, Catalina Márquez-Vega, Gianni Bisogno, Franca Fagioli, Virginia Ferraresi, Giuseppe Maria Milano, Luca Coccoli, Alba Rubio-San-Simón, Oscar Gallego, María Esther Llinares Riestra, Carla Manzitti, Jaume Mora, Mᵃ Ángeles Vaz-Salgado, Roberto Luksch, Cristina Mata, Michela Pierini, Elisa Carretta, Marilena Cesari, Anna Paioli, Andrea Marrari, Katia Scotlandi, Massimo Serra, Sebastian Dorin Asaftei, Marco Gambarotti, Piero Picci, Stefano Ferrari, Claudia Valverde, Toni Ibrahim, Javier Martín Broto Journal of Clinical Oncology, 2025
Early radiologic tumour volume response in non-metastatic rhabdomyosarcoma is not predictive for survival Isabelle S.A. de Vries, Carlo Morosi, Gianni Bisogno, Veronique Minard-Colin, Beatrice Coppadoro, Ilaria Zanetti, Andrea Ferrari, Daniel Orbach, Salma Moalla, Myriam Ben-Arush, Christine Devalck, Roelof van Ewijk, Kieran McHugh, Meriel Jenney, Julia Chisholm, Gabriela Guillen, Henry Mandeville, Johannes H. M. Merks, Rick R. Van Rijn Pediatric Radiology, 2025
European standard clinical practice recommendations for children and adolescents with Rhabdomyosarcoma a joint EpSSG, CWS and ERN PaedCan project Johannes H.M. Merks, Eva Brack, Martin Ebinger, Véronique Minard-Colin, Anne-Sophie Defachelles, Raquel Hladun, Timothy Rogers, Jörg Fuchs, Jan Godzinski, Sheila Terwisscha van Scheltinga, Gabriela Guillén Burrieza, Henry Mandeville, Beate Timmermann, Raquel Davila Fajardo, Rick R. van Rijn, Jürgen Schäfer, Helen Rees, Andrea Ferrari, Rita Alaggio, Anna Kelsey, Julia C. Chisholm, Christian Vokuhl, Monika Sparber-Sauer, Gianni Bisogno Ejc Paediatric Oncology, 2025
Parameningeal Rhabdomyosarcoma: Results of the European Pediatric Soft Tissue Sarcoma Study Group RMS 2005 Study Reineke A. Schoot, Pieter Taselaar, Giovanni Scarzello, Frederic Kolb, Beatrice Coppadoro, Simone ter Horst, Henry Mandeville, Andrea Ferrari, Raquel Hladun, Sylvie Helfre, Sima Ferman, Anna Kelsey, Marinka L. F. Hol, Christine Devalck, Myriam Ben‐Arush, Daniel Orbach, Julia Chisholm, Meriel Jenney, Veronique Minard‐Colin, Gianni Bisogno, Johannes H. M. Merks Head and Neck, 2025
Reply to “Toward a reduction in the burden of therapy in patients with rhabdomyosarcoma. How much is enough?” Henry C. Mandeville, Gianni Bisogno, Veronique Minard‐Colin, Rita Alaggio, Myriam Ben‐Arush, Cyrus Chargari, Beatrice Coppadoro, Ross Craigie, Christine Devalck, Sima Ferman, Andrea Ferrari, Heidi Glosli, Raquel Hladun Alvaro, Marinka Hol, Peter Mudry, Daniel Orbach, Monica Ramos Albiac, Johannes H. M. Merks, Meriel E. M. Jenney Cancer, 2025
The Impact of Radiation Therapy on Metastatic Rhabdomyosarcoma: Results From the EpSSG MTS 2008 Study Alison L. Cameron, Henry Mandeville, Beatrice Coppadoro, Manivannan Periasamy, Raquel Davila Fajardo, Andrea Ferrari, Mark N. Gaze, Sylvie Helfre, Henriette Magelssen, Veronique Minard-Colin, Monica Ramos, Reineke Schoot, Illaria Zanetti, Gianni Bisogno, Julia C. Chisholm, Johannes H.M. Merks International Journal of Radiation Oncology Biology Physics, 2025
Correction to: A joint international consensus statement for measuring quality of survival for patients with childhood cancer (Nature Medicine, (2023), 29, 6, (1340-1348), 10.1038/s41591-023-02339-y) Rebecca J. van Kalsbeek, Melissa M. Hudson, Renée L. Mulder, Matthew Ehrhardt, Daniel M. Green, Daniel A. Mulrooney, Jessica Hakkert, Jaap den Hartogh, Anouk Nijenhuis, Hanneke M. van Santen, Antoinette Y. N. Schouten-van Meeteren, Harm van Tinteren, Lisanne C. Verbruggen, Heather M. Conklin, Lisa M. Jacola, Rachel Tillery Webster, Marita Partanen, Wouter J. W. Kollen, Martha A. Grootenhuis, Rob Pieters, Leontien C. M. Kremer, , Rebecca J. van Kalsbeek, Jaap den Hartogh, Hanneke M. van Santen, Harm van Tinteren, Femke Aarsen, Madeleine Adams, Traci Adams, Chantal van den Akker, Roland Amman, Shekinah Andrews, Greg Armstrong, Andishe Attarbaschi, Amedeo Azizi, Kirsten van Baarsen, Simon Bailey, Justin Baker, Lisa Bakker-Provoost, Laura Beek, Peter Bekkering, Janneke van den Bergen, Esther van den Bergh, Marc Bierings, Michael Bishop, Gianni Bisogno, John Boatner, Saskia Boerboom, Judith de Bont, Frederick Boop, Cor van den Bos, Kim Boshuisen, Eric Bouffet, Rick Brandsma, Ida Bremer Ophorst, Bernadette Brennan, Rachel Brennan, Dorine Bresters, Sippy ten Brink, Laurence Brugières, Birgit Burkhardt, Gabriele Calaminus, Friso Calkoen, Kristin Canavera, Leeann Carmichael, Sharon Castellino, Michaela Cepelova, Wassim Chemaitilly, Julia Chisholm, Karen Clark, Debbie Crom, Amanda Curry, Brian DeFeo, Jennifer van Dijk, Stephanie Dixon, Jeffrey Dome, Jean Donadieu, Babet Drenth, Carlo Dufour, Adam Esbenshade, Gabriele Escherich, Taryn Fay-McClymont, Cécile Faure-Conter, Andrea Ferrari, Jamie Flerlage, Kayla Foster, Lindsay Frazier, Wayne Furman, Carlos Galindo-Rodriguez, Hoong-Wei Gan, Jessica Gartrell, James Geller, Corrie Gidding, Jan Godzinsky, Bianca Goemans, Richard Gorlick, Rinske Graafland, Norbert Graf, Martine van Grotel, Marjolein ter Haar, Valérie de Haas, Melanie Hagleitner, Karen Hale, Chris Halsey, Darren Hargrave, Jennifer Harman, Henrik Hasle, Riccardo Haupt, Lianne Haveman, Douglas Hawkins, Loek van der Heijden, Katja Heitink-Pollé, Marry van den Heuvel-Eibrink, Nobuko Hijiya, Lars Hjorth, Bianca Hoeben, Renske Houben, Eelco Hoving, Caroline Hulsker, Antoinette Jaspers, Liza Johnson, Niki Jurbergs, Lisa Kahalley, Seth Karol, Gertjan Kaspers, Erica Kaye, Anne Kazak, Rachèl Kemps, Tomas Kepak, Raja Khan, Paul Klimo, Rutger Knops, Andy Kolb, Rianne Koopman, Kathelijne Kraal, Christof Kramm, Matthew Krasin, Päivi Lähteenmäki, Judith Landman-Parker, Jeanette Lavecchia, Jurgen Lemiere, Angelia Lenschau, Charlotte Ligthart-Beukhof, Raphaële van Litsenburg, Jan Loeffen, Mignon Loh, John Lucas, Jasper van der Lugt, Peggy Lüttich, Renee Madden, Arshia Madni, John Maduro, Sanne van der Mark, Armanda Markesteijn, Christine Mauz-Koerholz, Annelies Mavinkurve, Lisethe Meijer, Thomas Merchant, Hans Merks, Bill Meyer, Friederike Meyer-Wentrup, Paul Meyers, Rebecka Meyers, Erna Michiels, Milen Minkov, Barbara de Moerloose, Kristen Molina, John Moppett, Kyle Morgan, Bruce Morland, Sabine Mueller, Hermann Müller, Roosmarijn Muller, Monica Muraca, Sandra Murphy, Vasanta Nanduri, Michael Neel, Charlotte Niemeyer, Max van Noesel, Maureen O’Brien, Daniel Orbach, Jale Özyurt, Heleen van der Pal, Vassilios Papadakis, Alberto Pappo, Lauren Pardue, Kendra Parris, Annemarie Peek, Bob Phillips, Sabine Plasschaert, Marieka Portegies, Brian Potter, Ibrahim Qaddoumi, Debbie Redd, Lineke Rehorst-Kleinlugtenbelt, Raul Ribeiro, Stephen Roberts, Jelena Roganovic, Stefan Rutkowski, Michiel van de Sande, Victor Santana, Stephanie Saslawsky, Kim Sawyer, Katrin Scheinemann, Gudrun Schleiermacher, Kjeld Schmiegelow, Reineke Schoot, Fiona Schulte, Astrid Sehested, Inge Sieswerda, Rod Skinner, Relinde Slooff, Donna Sluijs, Inge van der Sluis, Daniel Smith, Holly Spraker-Perlman, Sheri Spunt, Mirjam Sulkers, Teresa Sweeney, Mary Taj, Clifford Takemoto, Aimee Talleur, Hannah Taylor, Chantal Tersteeg, Sheila Terwisscha, Sophie Thomas, Brigitte Thomassen, Christopher Tinkle, Rebecca Tippett, Wim Tissing, Ingrid Tonning-Olsson, Anke Top, Erin Turner, Santhosh Upadhyaya, Anne Uyttebroeck, Güler Uyuk, Kees van de Ven, Birgitta Versluys, Emma Verwaaijen, Saphira Visser, Jochem van Vliet, Evelien de Vos-Kerkhof, Andrica de Vries, Dannis van Vuurden, Claire Wakefield, Katherine Warren, Chantal van Wegen Peelen, Aaron Weiss, Marianne van de Wetering, Jeremy Whelan, Romy Wichink, Lori Wiener, Marc Wijnen, Victoria Willard, Terry Wilson, Jennifer Windham, Laura de Winter, Olaf Witt, Marcin Wlodarski, Kim Wouters, Corina Wouterse, Kasey Wyrick, Lorna Zadravec Zaletel, Alia Zaidi, Jonne van Zanten, József Zsiros, Lisa Zwiers Nature Medicine, 2024
RAF1 gene fusions are recurrent driver events in infantile fibrosarcoma-like mesenchymal tumors Marialetizia Motta, Sabina Barresi, Simone Pizzi, Delfina Bifano, Jennifer Lopez Marti, Marta Garrido‐Pontnou, Elisabetta Flex, Alessandro Bruselles, Isabella Giovannoni, Giovannina Rotundo, Alessandra Fragale, Valentina Tirelli, Silvia Vallese, Andrea Ciolfi, Gianni Bisogno, Rita Alaggio, Marco Tartaglia Journal of Pathology, 2024
Focus on melanotic neuroectodermal tumor of infancy Malgorzata A. Krawczyk, Malgorzata Styczewska, Carla Fernandez, Rita Alaggio, Jaroslaw Szydlowski, Ines B. Brecht, Daniel Orbach, Dominik T. Schneider, Jelena Roganovic, Gianni Bisogno, Calogero Virgone, Jan Godzinski, Andrea Ferrari, Nuno Jorge Farinha, Tal Ben Ami, Luca Bergamaschi, Yves Réguerre, Ewa Bien Ejc Paediatric Oncology, 2024
Olfactory neuroblastoma in children and adolescents: The EXPeRT recommendations for diagnosis and management Daniela Di Carlo, Giulia Fichera, Benoit Dumont, Enrico Pozzo, Beate Timmermann, Romain Luscan, Antoine Moya-Plana, Anna Synakiewicz, Ewa Bien, Nino Jorge dos Reis Farinha, Malgorzata Krawczyk, Rita Alaggio, Apostolos Pourtsidis, Brice Fresneau, Yves Reguerre, Tal Ben-Ami, Calogero Virgone, Jelena Roganovic, Jan Godzinski, Ines B Brecht, Dominik Schneider, Andrea Ferrari, Barbara Hero, Daniel Orbach, Gianni Bisogno Ejc Paediatric Oncology, 2024
Diagnostic Utility of a Modified Reticulin Algorithm in Pediatric Adrenocortical Neoplasms Oscar Lopez-Nunez, Calogero Virgone, Irina S. Kletskaya, Luisa Santoro, Stefano Giuliani, Bruce Okoye, Marco Volante, Andrea Ferrari, Gianni Bisogno, Eleonora Duregon, Mauro Papotti, Gianluca De Salvo, Sarangarajan Ranganathan, Rita Alaggio American Journal of Surgical Pathology, 2024
Frontline and Relapsed Rhabdomyosarcoma (FaR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG) Julia Chisholm, Henry Mandeville, Madeleine Adams, Veronique Minard-Collin, Timothy Rogers, Anna Kelsey, Janet Shipley, Rick R. van Rijn, Isabelle de Vries, Roelof van Ewijk, Bart de Keizer, Susanne A. Gatz, Michela Casanova, Lisa Lyngsie Hjalgrim, Charlotte Firth, Keith Wheatley, Pamela Kearns, Wenyu Liu, Amanda Kirkham, Helen Rees, Gianni Bisogno, Ajla Wasti, Sara Wakeling, Delphine Heenen, Deborah A. Tweddle, Johannes H. M. Merks, Meriel Jenney Cancers, 2024
Correction to: A joint international consensus statement for measuring quality of survival for patients with childhood cancer (Nature Medicine, (2023), 29, 6, (1340-1348), 10.1038/s41591-023-02339-y) Rebecca J. van Kalsbeek, Melissa M. Hudson, Renée L. Mulder, Matthew Ehrhardt, Daniel M. Green, Daniel A. Mulrooney, Jessica Hakkert, Jaap den Hartogh, Anouk Nijenhuis, Hanneke M. van Santen, Antoinette Y. N. Schouten-van Meeteren, Harm van Tinteren, Lisanne C. Verbruggen, Heather M. Conklin, Lisa M. Jacola, Rachel Tillery Webster, Marita Partanen, Wouter J. W. Kollen, Martha A. Grootenhuis, Rob Pieters, Leontien C. M. Kremer, , Jaap den Hartogh, Rebecca J. van Kalsbeek, Hanneke M. van Santen, Harm van Tinteren, Femke Aarsen, Madeleine Adams, Traci Adams, Chantal van den Akker, Roland Amman, Shekinah Andrews, Greg Armstrong, Andishe Atterbaschi, Amedeo Azizi, Kirsten van Baarsen, Simon Bailey, Justin Baker, Lisa Bakker-Provoost, Laura Beek, Peter Bekkering, Janneke van den Bergen, Esther van den Bergh, Marc Bierings, Michael Bishop, Gianni Bisogno, John Boatner, Saskia Boerboom, Judith de Bont, Frederick Boop, Cor van den Bos, Eric Bouffet, Rick Brandsma, Ida Bremer Ophorst, Bernadette Brennan, Rachel Brennan, Dorine Bresters, Sippy ten Brink, Laurence Brugières, Birgit Burkhardt, Gabriele Calaminus, Friso Calkoen, Kristin Canavera, Leeann Carmichael, Sharon Castellino, Michaela Cepelova, Wassim Chemaitilly, Julia Chisholm, Karen Clark, Heather Conklin, Debbie Crom, Amanda Curry, Brian DeFeo, Jennifer van Dijk, Stephanie Dixon, Jeffrey Dome, Jean Donadieu, Babet Drenth, Carlo Dufour, Adam Esbenshade, Gabriele Escherich, Taryn Fay-McClymont, Cécile Faure-Conter, Andrea Ferrari, Jamie Flerlage, Kayla Foster, Lindsay Frazier, Wayne Furman, Carlos Galindo-Rodriguez, Hoong-Wei Gan, Jessica Gartrell, James Geller, Corrie Gidding, Jan Godzinsky, Bianca Goemans, Richard Gorlick, Rinske Graafland, Norbert Graf, Daniel Green, Martha Grootenhuis, Martine van Grotel, Marjolein ter Haar, Valérie de Haas, Melanie Hagleitner, Karen Hale, Chris Halsey, Darren Hargrave, Jennifer Harman, Henrik Hasle, Riccardo Haupt, Lianne Haveman, Douglas Hawkins, Loek van der Heijden, Katja Heitink-Pollé, Marry van den Heuvel-Eibrink, Nobuko Hijiya, Lars Hjorth, Bianca Hoeben, Renske Houben, Eelco Hoving, Melissa Hudson, Caroline Hulsker, Lisa Jacola, Antoinette Jaspers, Liza Johnson, Niki Jurbergs, Lisa Kahalley, Rebecca van Kalsbeek, Seth Karol, Gertjan Kaspers, Erica Kaye, Anne Kazak, Rachèl Kemps, Tomas Kepak, Raja Khan, Paul Klimo, Rutger Knops, Andy Kolb, Wouter Kollen, Rianne Koopman, Kathelijne Kraal, Christof Kramm, Matthew Krasin, Leontien Kremer, Päivi Lähteenmäki, Judith Landman-Parker, Jeanette Lavecchia, Jurgen Lemiere, Angelia Lenschau, Charlotte Ligthart-Beukhof, Raphaële van Litsenburg, Jan Loeffen, Mignon Loh, John Lucas, Jasper van der Lugt, Peggy Lüttich, Renee Madden, Arshia Madni, John Maduro, Sanne van der Mark, Armanda Markesteijn, Christine Mauz-Koerholz, Annelies Mavinkurve, Lisethe Meijer, Thomas Merchant, Hans Merks, Bill Meyer, Friederike Meyer-Wentrup, Paul Meyers, Rebecka Meyers, Erna Michiels, Milen Minkov, Barbara de Moerloose, Kristen Molina, John Moppett, Kyle Morgan, Bruce Morland, Sabine Mueller, Renée Mulder, Hermann Müller, Roosmarijn Muller, Daniel Mulrooney, Monica Muraca, Sandra Murphy, Vasanta Nanduri, Michael Neel, Charlotte Niemeyer, Maureen O’Brien, Daniel Orbach, Jale Özyurt, Heleen van der Pal, Vassilios Papadakis, Alberto Pappo, Lauren Pardue, Kendra Parris, Annemarie Peek, Bob Phillips, Sabine Plasschaert, Marieka Portegies, Brian Potter, Ibrahim Qaddoumi, Debbie Redd, Lineke Rehorst-Kleinlugtenbelt, Stephen Roberts, Jelena Roganovic, Stefan Rutkowski, Michiel van de Sande, Victor Santana, Hanneke van Santen, Stephanie Saslawsky, Kim Sawyer, Katrin Scheinemann, Gudrun Schleiermacher, Kjeld Schmiegelow, Reineke Schoot, Antoinette Schouten-van Meeteren, Fiona Schulte, Astrid Sehested, Inge Sieswerda, Rod Skinner, Relinde Slooff, Donna Sluijs, Inge van der Sluis, Daniel Smith, Holly Spraker-Perlman, Sheri Spunt, Mirjam Sulkers, Teresa Sweeney, Mary Taj, Clifford Takemoto, Aimee Talleur, Hannah Taylor, Chantal Tersteeg, Sheila Terwisscha, Sophie Thomas, Brigitte Thomassen, Christopher Tinkle, Rebecca Tippett, Wim Tissing, Ingrid Tonning-Olsson, Anke Top, Erin Turner, Santhosh Upadhyaya, Anne Uyttebroeck, Güler Uyuk, Kees van de Ven, Lisanne Verbruggen, Birgitta Versluys, Emma Verwaaijen, Saphira Visser, Jochem van Vliet, Evelien de Vos-Kerkhof, Andrica de Vries, Dannis van Vuurden, Claire Wakefield, Katherine Warren, Chantal van Wegen Peelen, Aaron Weiss, Marianne van de Wetering, Jeremy Whelan, Romy Wichink, Lori Wiener, Marc Wijnen, Victoria Willard, Terry Wilson, Jennifer Windham, Laura de Winter, Olaf Witt, Marcin Wlodarski, Kim Wouters, Corina Wouterse, Kasey Wyrick, Lorna Zadravec Zaletel, Alia Zaidi, Jonne van Zanten, József Zsiros, Lisa Zwiers Nature Medicine, 2024
Author Correction: A joint international consensus statement for measuring quality of survival for patients with childhood cancer (Nature Medicine, (2023), 29, 6, (1340-1348), 10.1038/s41591-023-02339-y) Rebecca J. van Kalsbeek, Melissa M. Hudson, Renée L. Mulder, Matthew Ehrhardt, Daniel M. Green, Daniel A. Mulrooney, Jessica Hakkert, Jaap den Hartogh, Anouk Nijenhuis, Hanneke M. van Santen, Antoinette Y. N. Schouten-van Meeteren, Harm van Tinteren, Lisanne C. Verbruggen, Heather M. Conklin, Lisa M. Jacola, Rachel Tillery Webster, Marita Partanen, Wouter J. W. Kollen, Martha A. Grootenhuis, Rob Pieters, Leontien C. M. Kremer, Rebecca J. van Kalsbeek, Jaap den Hartogh, Hanneke M. van Santen, Harm van Tinteren, Femke Aarsen, Madeleine Adams, Traci Adams, Chantal van den Akker, Roland Amman, Shekinah Andrews, Greg Armstrong, Andishe Attarbaschi, Amedeo Azizi, Kirsten van Baarsen, Simon Bailey, Justin Baker, Lisa Bakker-Provoost, Laura Beek, Peter Bekkering, Janneke van den Bergen, Esther van den Bergh, Marc Bierings, Michael Bishop, Gianni Bisogno, John Boatner, Saskia Boerboom, Judith de Bont, Frederick Boop, Cor van den Bos, Eric Bouffet, Rick Brandsma, Ida Bremer Ophorst, Bernadette Brennan, Rachel Brennan, Dorine Bresters, Sippy ten Brink, Laurence Brugières, Birgit Burkhardt, Gabriele Calaminus, Friso Calkoen, Kristin Canavera, Leeann Carmichael, Sharon Castellino, Michaela Cepelova, Wassim Chemaitilly, Julia Chisholm, Karen Clark, Debbie Crom, Amanda Curry, Brian DeFeo, Jennifer van Dijk, Stephanie Dixon, Jeffrey Dome, Jean Donadieu, Babet Drenth, Carlo Dufour, Adam Esbenshade, Gabriele Escherich, Taryn Fay-McClymont, Cécile Faure-Conter, Andrea Ferrari, Jamie Flerlage, Kayla Foster, Lindsay Frazier, Wayne Furman, Carlos Galindo-Rodriguez, Hoong-Wei Gan, Jessica Gartrell, James Geller, Corrie Gidding, Jan Godzinsky, Bianca Goemans, Richard Gorlick, Rinske Graafland, Norbert Graf, Martine van Grotel, Marjolein ter Haar, Valérie de Haas, Melanie Hagleitner, Karen Hale, Chris Halsey, Darren Hargrave, Jennifer Harman, Henrik Hasle, Riccardo Haupt, Lianne Haveman, Douglas Hawkins, Loek van der Heijden, Katja Heitink-Pollé, Marry van den Heuvel-Eibrink, Nobuko Hijiya, Lars Hjorth, Bianca Hoeben, Renske Houben, Eelco Hoving, Caroline Hulsker, Antoinette Jaspers, Liza Johnson, Niki Jurbergs, Lisa Kahalley, Seth Karol, Gertjan Kaspers, Erica Kaye, Anne Kazak, Rachèl Kemps, Tomas Kepak, Raja Khan, Paul Klimo, Rutger Knops, Andy Kolb, Rianne Koopman, Kathelijne Kraal, Christof Kramm, Matthew Krasin, Päivi Lähteenmäki, Judith Landman-Parker, Jeanette Lavecchia, Jurgen Lemiere, Angelia Lenschau, Charlotte Ligthart-Beukhof, Raphaële van Litsenburg, Jan Loeffen, Mignon Loh, John Lucas, Jasper van der Lugt, Peggy Lüttich, Renee Madden, Arshia Madni, John Maduro, Sanne van der Mark, Armanda Markesteijn, Christine Mauz-Koerholz, Annelies Mavinkurve, Lisethe Meijer, Thomas Merchant, Hans Merks, Bill Meyer, Friederike Meyer-Wentrup, Paul Meyers, Rebecka Meyers, Erna Michiels, Milen Minkov, Barbara de Moerloose, Kristen Molina, John Moppett, Kyle Morgan, Bruce Morland, Sabine Mueller, Hermann Müller, Roosmarijn Muller, Monica Muraca, Sandra Murphy, Vasanta Nanduri, Michael Neel, Charlotte Niemeyer, Maureen O’Brien, Daniel Orbach, Jale Özyurt, Heleen van der Pal, Vassilios Papadakis, Alberto Pappo, Lauren Pardue, Kendra Parris, Annemarie Peek, Bob Phillips, Sabine Plasschaert, Marieka Portegies, Brian Potter, Ibrahim Qaddoumi, Debbie Redd, Lineke Rehorst-Kleinlugtenbelt, Stephen Roberts, Jelena Roganovic, Stefan Rutkowski, Michiel van de Sande, Victor Santana, Stephanie Saslawsky, Kim Sawyer, Katrin Scheinemann, Gudrun Schleiermacher, Kjeld Schmiegelow, Reineke Schoot, Fiona Schulte, Astrid Sehested, Inge Sieswerda, Rod Skinner, Relinde Slooff, Donna Sluijs, Inge van der Sluis, Daniel Smith, Holly Spraker-Perlman, Sheri Spunt, Mirjam Sulkers, Teresa Sweeney, Mary Taj, Clifford Takemoto, Aimee Talleur, Hannah Taylor, Chantal Tersteeg, Sheila Terwisscha, Sophie Thomas, Brigitte Thomassen, Christopher Tinkle, Rebecca Tippett, Wim Tissing, Ingrid Tonning-Olsson, Anke Top, Erin Turner, Santhosh Upadhyaya, Anne Uyttebroeck, Güler Uyuk, Kees van de Ven, Birgitta Versluys, Emma Verwaaijen, Saphira Visser, Jochem van Vliet, Evelien de Vos-Kerkhof, Andrica de Vries, Dannis van Vuurden, Claire Wakefield, Katherine Warren, Chantal van Wegen Peelen, Aaron Weiss, Marianne van de Wetering, Jeremy Whelan, Romy Wichink, Lori Wiener, Marc Wijnen, Victoria Willard, Terry Wilson, Jennifer Windham, Laura de Winter, Olaf Witt, Marcin Wlodarski, Kim Wouters, Corina Wouterse, Kasey Wyrick, Lorna Zadravec Zaletel, Alia Zaidi, Jonne van Zanten, József Zsiros, Lisa Zwiers, and Nature Medicine, 2024
Age-related biological differences in children's and adolescents’ very rare tumors Calogero Virgone, Tal Ben Ami, Jelena Roganovic, Ewa Bien, Yves Reguerre, Andrea Ferrari, Daniel Orbach, Jan Godzinski, Gianni Bisogno, Nuno Jorge Farinha, Luca Bergamaschi, Rita Alaggio, Michaela Kuhlen, Michael Abele, Abbas Agaimy, Dominik T. Schneider, Ines B. Brecht Ejc Paediatric Oncology, 2023
The role of cancer predisposition syndrome in children and adolescents with very rare tumours Daniel Orbach, Ines B. Brecht, Nadege Corradini, Yassine Bouchoucha, Jelena Roganovic, Franck Bourdeaut, Yves Reguerre, Roland P. Kuiper, Brigitte Bressac de Paillerets, Andrea Ferrari, Calogero Virgone, Jan Godzinski, Gianni Bisogno, Lea Guerrini-Rousseau, Nuno Jorge Farinha, Luca Bergamaschi, Ewa Bien, Michaela Kuhlen, Dominik T. Schneider, Tal Ben Ami Ejc Paediatric Oncology, 2023
Quantitative diffusion-weighted MRI response assessment in rhabdomyosarcoma: an international retrospective study on behalf of the European paediatric Soft tissue sarcoma Study Group Imaging Committee Roelof van Ewijk, Cyrano Chatziantoniou, Madeleine Adams, Patrizia Bertolini, Gianni Bisogno, Amine Bouhamama, Pablo Caro-Dominguez, Valerie Charon, Ana Coma, Rana Dandis, Christine Devalck, Giulia De Donno, Andrea Ferrari, Marta Fiocco, Soledad Gallego, Chiara Giraudo, Heidi Glosli, Simone A. J. ter Horst, Meriel Jenney, Willemijn M. Klein, Alexander Leemans, Julie Leseur, Henry C. Mandeville, Kieran McHugh, Johannes H. M. Merks, Veronique Minard-Colin, Salma Moalla, Carlo Morosi, Daniel Orbach, Lil-Sofie Ording Muller, Erika Pace, Pier Luigi Di Paolo, Katia Perruccio, Lucia Quaglietta, Marleen Renard, Rick R. van Rijn, Antonio Ruggiero, Sara I. Sirvent, Alberto De Luca, Reineke A. Schoot Pediatric Radiology, 2023
Maintenance Chemotherapy for Patients with Rhabdomyosarcoma Gianni Bisogno, Veronique Minard-Colin, Meriel. Jenney, Andrea Ferrari, Julia Chisholm, Daniela Di Carlo, Lisa Lyngsie Hjalgrim, Daniel Orbach, Johannes Hendrikus Maria Merks, Michela Casanova Cancers, 2023
NUT Carcinoma in Children and Adolescents: The Expert European Standard Clinical Practice Harmonized Recommendations Lauriane Lemelle, Tim Flaadt, Brice Fresneau, Antoine Moya-Plana, Beate Timmermann, Jelena Roganovic, Andrea Ferrari, Giulia Fichera, Ulrich M. Lauer, Tal Ben-Ami, Dominik T. Schneider, Christian Vokuhl, Stephanie Bolle, Elisabeth Fox, Steven G. DuBois, Carlos Rodriguez-Galindo, Gianni Bisogno, Aurore Surun, Ines B. Brecht, Daniel Orbach Journal of Pediatric Hematology Oncology, 2023
Pediatric BCOR-Altered Tumors From Soft Tissue/Kidney Display Specific DNA Methylation Profiles Claudia M. Salgado, Rita Alaggio, Andrea Ciolfi, Angelica Zin, Francesca Diomedi Camassei, Lucia Pedace, Giuseppe Maria Milano, Annalisa Serra, Angela Di Giannatale, Angela Mastronuzzi, Andrea Gianatti, Gianni Bisogno, Andrea Ferrari, Marco Tartaglia, Miguel Reyes-Múgica, Franco Locatelli, Evelina Miele Modern Pathology, 2023
Shedding a Light on the Challenges of Adolescents and Young Adults with Rhabdomyosarcoma Andrea Ferrari, Susanne Andrea Gatz, Veronique Minard-Colin, Rita Alaggio, Shushan Hovsepyan, Daniel Orbach, Patrizia Gasparini, Anne-Sophie Defachelles, Michela Casanova, Giuseppe Maria Milano, Julia C. Chisholm, Meriel Jenney, Gianni Bisogno, Timothy Rogers, Henry C. Mandeville, Janet Shipley, Aisha B. Miah, Johannes H. M. Merks, Winette T. A. van der Graaf Cancers, 2022
Creating a data commons: The INternational Soft Tissue SaRcoma ConsorTium (INSTRuCT) Kirk D. Wyatt, Suzi Birz, Douglas S. Hawkins, Veronique Minard‐Colin, David A. Rodeberg, Monika Sparber‐Sauer, Gianni Bisogno, Ewa Koscielniak, Gian Luca De Salvo, Martin Ebinger, Johannes H. M. Merks, Suzanne L. Wolden, Wei Xue, Samuel L. Volchenboum, and Pediatric Blood and Cancer, 2022
Perianal/perineal rhabdomyosarcoma: Results of the SIOP MMT 95, Italian RMS 96, and EpSSG RMS 2005 studies Timothy Rogers, Ilaria Zanetti, Beatrice Coppadoro, Hélène Martelli, Meriel Jenney, Veronique Minard‐Colin, Sheila E. J. Terwisscha van Scheltinga, Clare Skerritt, Raquel Dávila Fajardo, Florent Guérin, Anna Kelsey, Johannes H. M. Merks, Henry Mandeville, Gabriela Guillén, Heidi Glosli, Federica De Corti, Gianni Bisogno Pediatric Blood and Cancer, 2022
Congenital spindle cell rhabdomyosarcoma: An international cooperative analysis Sarah Whittle, Rajkumar Venkatramani, Anton Schönstein, Svetlana D. Pack, Rita Alaggio, Christian Vokuhl, Erin R. Rudzinski, Anna–Lena Wulf, Angelica Zin, Juliana R. Gruver, Michael A. Arnold, Johannes H.M. Merks, Simone Hettmer, Ewa Koscielniak, Frederic G. Barr, Douglas S. Hawkins, Gianni Bisogno, Monika Sparber-Sauer European Journal of Cancer, 2022
Reply to H. B et al Anne-Sophie Defachelles, Emilie Bogart, Michela Casanova, Johannes H.M. Merks, Gianni Bisogno, Giuseppina Calareso, Soledad Gallego Melcon, Susanne Andrea Gatz, Marie-Cécile Le Deley, Kieran McHugh, Alicia Probst, Nathalie Rocourt, Rick R. van Rijn, Véronique Minard-Colin, Julia C. Chisholm Journal of Clinical Oncology, 2022
Molecular Characterization of Circulating Tumor DNA in Pediatric Rhabdomyosarcoma: A Feasibility Study Olivia Ruhen, Nathalie S.M. Lak, Janine Stutterheim, Sara G. Danielli, Mathieu Chicard, Yasmine Iddir, Alexandra Saint-Charles, Virginia Di Paolo, Lucia Tombolan, Susanne A. Gatz, Ewa Aladowicz, Paula Proszek, Sabri Jamal, Reda Stankunaite, Deborah Hughes, Paul Carter, Elisa Izquierdo, Ajla Wasti, Julia C. Chisholm, Sally L. George, Erika Pace, Louis Chesler, Isabelle Aerts, Gaelle Pierron, Sakina Zaidi, Olivier Delattre, Didier Surdez, Anna Kelsey, Michael Hubank, Paolo Bonvini, Gianni Bisogno, Angela Di Giannatale, Gudrun Schleiermacher, Beat W. Schäfer, Godelieve A.M. Tytgat, Janet Shipley JCO Precision Oncology, 2022
The Impact of Radiation Therapy in Children and Adolescents With Metastatic Rhabdomyosarcoma Alison L. Cameron, Markus C. Elze, Michela Casanova, Birgit Geoerger, Mark N. Gaze, Veronique Minard-Colin, Kieran McHugh, Rick R. van Rijn, Anna Kelsey, Hélène Martelli, Henry Mandeville, Gianni Bisogno, Stephen Lowis, Milind Ronghe, Daniel Orbach, Cecile Guizani, Sabine Fürst-Recktenwald, Julia C. Chisholm, Johannes H.M. Merks International Journal of Radiation Oncology Biology Physics, 2021
Melanoma in Adolescents and Young Adults: Evaluation of the Characteristics, Treatment Strategies, and Prognostic Factors in a Monocentric Retrospective Study Paolo Del Fiore, Irene Russo, Beatrice Ferrazzi, Alessandro Dal Monico, Francesco Cavallin, Angela Filoni, Saveria Tropea, Francesco Russano, Claudia Di Prata, Alessandra Buja, Alessandra Collodetto, Romina Spina, Sabrina Carraro, Rocco Cappellesso, Lorenzo Nicolè, Vanna Chiarion-Sileni, Jacopo Pigozzo, Luigi Dall’Olmo, Marco Rastrelli, Antonella Vecchiato, Clara Benna, Chiara Menin, Daniela Di Carlo, Gianni Bisogno, Angelo Paolo Dei Tos, Mauro Alaibac, Simone Mocellin Frontiers in Oncology, 2021
Cutaneous melanoma in children and adolescents: The EXPeRT/PARTNER diagnostic and therapeutic recommendations Andrea Ferrari, Ricardo Lopez Almaraz, Yves Reguerre, Maja Cesen, Luca Bergamaschi, Alice Indini, Dominik T. Schneider, Jan Godzinski, Ewa Bien, Teresa Stachowicz‐Stencel, Thomas K. Eigentler, Stefano Chiaravalli, Malgorzata A. Krawczyk, Alberto Pappo, Daniel Orbach, Gianni Bisogno, Ines B. Brecht Pediatric Blood and Cancer, 2021
Adrenocortical tumours in children and adolescents: The EXPeRT/PARTNER diagnostic and therapeutic recommendations Calogero Virgone, Jelena Roganovic, Peter Vorwerk, Antje Redlich, Dominik T. Schneider, Dragana Janic, Ewa Bien, Ricardo López‐Almaraz, Jan Godzinski, Gustaf Osterlundh, Teresa Stachowicz‐Stencel, Laurence Brugières, Ines B. Brecht, Cécile Thomas‐Teinturier, Brice Fresneau, Aurore Surun, Andrea Ferrari, Gianni Bisogno, Daniel Orbach Pediatric Blood and Cancer, 2021
Pancreatoblastoma in children: EXPeRT/PARTNER diagnostic and therapeutic recommendations Ewa Bien, Jelena Roganovic, Malgorzata A. Krawczyk, Jan Godzinski, Daniel Orbach, Giovanni Cecchetto, Winfred Barthlen, Anne‐Sophie Defachelles, Andrea Ferrari, Christopher B. Weldon, Ines B. Brecht, Dominik T. Schneider, Gianni Bisogno, Alexandra Kolenova, Tal Ben‐Ami, Kata Martinova, Calogero Virgone, Teresa Stachowicz‐Stencel, Denis Kachanov, Yves Reguerre Pediatric Blood and Cancer, 2021
Impact of Rhabdomyosarcoma Treatment Modalities by Age in a Population-Based Setting Andrea Ferrari, Alice Bernasconi, Luca Bergamaschi, Laura Botta, Anita Andreano, Marine Castaing, Massimo Rugge, Gianni Bisogno, Fabio Falcini, Carlotta Sacerdote, Giovanna Tagliabue, Maria Michiara, Claudia Cirilli, Alessandro Barchielli, Rosa Angela Filiberti, Maria Francesca Vitale, Rosario Tumino, Fabrizio Stracci, Stefano Chiaravalli, Michela Casanova, Patrizia Gasparini, Giuseppe Maria Milano, Gemma Gatta, Annalisa Trama Journal of Adolescent and Young Adult Oncology, 2021
Pleuropulmonary blastoma in children and adolescents: The EXPeRT/PARTNER diagnostic and therapeutic recommendations Gianni Bisogno, Sabine Sarnacki, Teresa Stachowicz‐Stencel, V. Minard Colin, Andrea Ferrari, Jan Godzinski, Marion Gauthier Villars, Ewa Bien, Frederic Hameury, Sylvie Helfre, Dominik T. Schneider, Yves Reguerre, Ricardo Lopez Almaraz, Dragana Janic, Maja Cesen, Alexandra Kolenova, Jelena Rascon, Kata Martinova, Rodica Cosnarovici, Apostolos Pourtsidis, Tal Ben Ami, Jelena Roganovic, Ewa Koscielniak, Kris Ann P. Schultz, Ines B. Brecht, Daniel Orbach Pediatric Blood and Cancer, 2021
Nasopharyngeal carcinoma in children and adolescents: The EXPeRT/PARTNER diagnostic and therapeutic recommendations Tal Ben‐Ami, Udo Kontny, Aurore Surun, Ines B. Brecht, Ricardo López Almaraz, Monica Dragomir, Apostolos Pourtsidis, Michela Casanova, Brice Fresneau, Gianni Bisogno, Dominik T. Schneider, Yves Reguerre, Ewa Bien, Teresa Stachowicz‐Stencel, Gustaf Österlundh, Marc Wygoda, Geert O Janssens, József Zsiros, Nina Jehanno, Herve J Brisse, Lorenza Gandola, Hans Christiansen, Line Claude, Andrea Ferrari, Carlos Rodriguez‐Galindo, Daniel Orbach Pediatric Blood and Cancer, 2021
Extra-appendicular neuroendocrine tumors: A report from the TREP project (2000-2020) Calogero Virgone, Andrea Ferrari, Stefano Chiaravalli, Maria Debora De Pasquale, Alessandro Inserra, Paolo D'Angelo, Martina Funmilayo Ogunleye, Alessandro Crocoli, Stefano Vallero, Simone Cesaro, Rita Alaggio, Gianni Bisogno, Patrizia Dall'Igna Pediatric Blood and Cancer, 2021
Embryonal rhabdomyosarcoma completely resected at diagnosis: The European paediatric Soft tissue sarcoma Study Group RMS2005 experience Christophe Bergeron, Meriel Jenney, Federica De Corti, Soledad Gallego, Hans Merks, Heidi Glosli, Andrea Ferrari, Dominique Ranchère-Vince, Gian Luca De Salvo, Ilaria Zanetti, Julia Chisholm, Véronique Minard-Colin, Timothy Rogers, Gianni Bisogno, Adriana Rose, Christine Devalck, Sima Ferman, Peter Mudry, Christophe Bergeron, Myriam Weyl Ben Arush, Gianni Bisogno, Heidi Glosli, Daniela Sejnova, Maja Cesen, Soledad Gallego, J. Hans Merks, Meriel Jenney European Journal of Cancer, 2021
Alveolar rhabdomyosarcoma with regional nodal involvement: Results of a combined analysis from two cooperative groups Soledad Gallego, Yueh‐Yun Chi, Gian Luca De Salvo, Minjie Li, Johannes H.M. Merks, David A. Rodeberg, Sheila Terwisscha van Scheltinga, Leo Mascarenhas, Daniel Orbach, Meriel Jenney, Lynn Million, Veronique Minard‐Colin, Suzanne Wolden, Ilaria Zanetti, David M. Parham, Henry Mandeville, Rajkumar Venkatramani, Gianni Bisogno, Douglas S. Hawkins, European paediatric Soft tissue sarcoma Study Group, Children's Oncology Group Pediatric Blood and Cancer, 2021
Pediatric Cancer Data Commons: Federating and Democratizing Data for Childhood Cancer Research Alejandro Plana, Brian Furner, Monica Palese, Nicole Dussault, Suzi Birz, Luca Graglia, Maura Kush, James Nicholson, Stefanie Hecker-Nolting, Nathalie Gaspar, Mareike Rasche, Gianni Bisogno, Dirk Reinhardt, C. Michel Zwaan, Ewa Koscielniak, A. Lindsay Frazier, Katherine Janeway, Douglas S. Hawkins, E. Anders Kolb, Susan L. Cohn, Andrew D. J. Pearson, Samuel L. Volchenboum JCO Clinical Cancer Informatics, 2021
Local staging and treatment in extremity rhabdomyosarcoma. A report from the EpSSG-RMS2005 study Sheila E. J. Terwisscha van Scheltinga, Marc H. W. A. Wijnen, Hélène Martelli, Timothy Rogers, Henry Mandeville, Mark N. Gaze, Keiran McHugh, Nadege Corradini, Daniel Orbach, Meriel Jenney, Anna Kelsey, Julia Chisholm, Soledad Gallego, Heidi Glosli, Andrea Ferrari, Ilaria Zanetti, Gian Luca De Salvo, Veronique Minard‐Colin, Giani Bisogno, Max M. van Noesel, Hans H. M. Merks Cancer Medicine, 2020
Pheochromocytomas and paragangliomas in children: Data from the Italian Cooperative Study (TREP) Calogero Virgone, Marina Andreetta, Stefano Avanzini, Stefano Chiaravalli, Maria Debora De Pasquale, Alessandro Crocoli, Alessandro Inserra, Paolo D'Angelo, Rita Alaggio, Giuseppe Opocher, Giovanni Cecchetto, Andrea Ferrari, Gianni Bisogno, Patrizia Dall'Igna Pediatric Blood and Cancer, 2020
Pediatric airway tumors: A report from the International Network of Pediatric Airway Teams (INPAT) Luca Pio, Patricio Varela, Martin J. Eliott, Vincent Couloigner, Gabriela Guillén Burrieza, Irene Paraboschi, Calogero Virgone, Rebecca Maunsell, Victor Rachkov, Michael J. Rutter, Mariano Boglione, Jaime Penchyna Grub, Gastón Bellía Munzón, Sabine Sarnacki, Sabine Irtan, Claudia Schweiger, Michèle Larroquet, Naziha Khen Dunlop, Madhavan Ramaswamy, Angela Pistorio, Giovanni Cecchetto, Andrea Ferrari, Gianni Bisogno, Michele Torre Laryngoscope, 2020
Prognostic role of pleural effusion or ascites in localized rhabdomyosarcoma Daniela Di Carlo, Andrea Ferrari, Tiziana Toffolutti, Giuseppe Maria Milano, Carla Manzitti, Antonio Ruggiero, Patrizia Dall'Igna, Fraia Melchionda, Ilaria Zanetti, Giovanni Scarzello, Gianni Bisogno Pediatric Blood and Cancer, 2019
Localized vaginal/uterine rhabdomyosarcoma—results of a pooled analysis from four international cooperative groups Veronique Minard‐Colin, David Walterhouse, Gianni Bisogno, Helene Martelli, James Anderson, David A. Rodeberg, Andrea Ferrari, Meriel Jenney, Suzanne Wolden, Gianluca De Salvo, Carola Arndt, Johannes H. M. Merks, Soledad Gallego, Dominique Schwob, Christine Haie‐Meder, Christophe Bergeron, Michael C. G. Stevens, Odile Oberlin, Douglas Hawkins, International Society of Pediatric Oncology Sarcoma Committee, the Children's Oncology Group, the Italian Cooperative Soft Tissue Sarcoma Group, the European pediatric Soft tissue sarcoma Study Group Pediatric Blood and Cancer, 2018
Addition of dose-intensified doxorubicin to standard chemotherapy for rhabdomyosarcoma (EpSSG RMS 2005): a multicentre, open-label, randomised controlled, phase 3 trial Gianni Bisogno, Meriel Jenney, Christophe Bergeron, Soledad Gallego Melcón, Andrea Ferrari, Odile Oberlin, Modesto Carli, Michael Stevens, Anna Kelsey, Angela De Paoli, Mark N Gaze, Helene Martelli, Christine Devalck, Johannes H Merks, Myriam Ben-Arush, Heidi Glosli, Julia Chisholm, Daniel Orbach, Veronique Minard-Colin, Gian Luca De Salvo, Maja Cesen, Adriana Rose, Sima Ferman, Peter Mudry, Daniela Sejnova, Paola Dal Bianco, Ilaria Zanetti, Felix Niggli, Timothy Rogers, Giovanni Cecchetto, Federica De Corti, Florent Guerin, Sheila Terwisscha, Dominique Ranchere, Rita Alaggio, Janet Shipley, Angelo Rosolen, Henry Mandeville, Giovanni Scarzello, Valerie Bernier, Kieran McHugh Lancet Oncology, 2018
Pediatric patients with cutaneous melanoma: A European study Ines B. Brecht, Angela De Paoli, Gianni Bisogno, Daniel Orbach, Dominik T. Schneider, Ulrike Leiter, Sonja Offenmueller, Giovanni Cecchetto, Jan Godzinski, Ewa Bien, Teresa Stachowicz‐Stencel, Tal Ben‐Ami, Stefano Chiaravalli, Andrea Maurichi, Gian Luca De Salvo, Silvia Sorbara, Christine Bodemer, Claus Garbe, Yves Reguerre, Andrea Ferrari Pediatric Blood and Cancer, 2018
Gastrointestinal tract carcinoma in pediatric and adolescent age: The Italian TREP project experience Alice Indini, Gianni Bisogno, Giovanni Cecchetto, Marco Vitellaro, Stefano Signoroni, Maura Massimino, Giovanna Riccipetitoni, Marco Zecca, Patrizia Dall'Igna, Maria Debora De Pasquale, Alessandro Inserra, Stefano Chiaravalli, Eleonora Basso, Calogero Virgone, Silvia Sorbara, Maria Di Bartolomeo, Paolo D'Angelo, Andrea Ferrari Pediatric Blood and Cancer, 2017
New insights into sinusoidal obstruction syndrome Andrea Piccin, Maria T. Sartori, Gianni Bisogno, Muriel Van Schilfgaarde, Graziella Saggiorato, Angela M. D. Pierro, Daisy Corvetta, Luigi Marcheselli, Andrea Mega, Günther Gastl, Simone Cesaro Internal Medicine Journal, 2017
Pediatric nonrhabdomyosarcoma soft tissue sarcomas arising at visceral sites Andrea Ferrari, Chiara Magni, Luca Bergamaschi, Giovanni Cecchetto, Rita Alaggio, Giuseppe Maria Milano, Patrizia Bertolini, Eleonora Basso, Carla Manzitti, Martina Di Martino, Nauga Giurici, Fraia Melchionda, Valerio Cecinati, Stefano Chiaravalli, Maria Carmen Affinita, Angela Scagnellato, Michela Casanova, Gianni Bisogno Pediatric Blood and Cancer, 2017
Winners' cup: A national football tournament brings together Adolescent patients with cancer from all over Italy Matteo Silva, Marco Chisari, Stefano Signoroni, Alberto Bassani, Luca Tagliabue, Angelo Ricci, Mirco Daversa, Massimo Achini, Filippo Spreafico, Michele Murelli, Giuseppe Maria Milano, Gianni Bisogno, Luca Coccoli, Massimo Conte, Alberto Garaventa, Paolo Indolfi, Silverio Perrotta, Marco Spinelli, Federico Mercolini, Pietro Soloni, Marta Pierobon, Andrea Di Cataldo, Teresa Perillo, Maurizio Mascarin, Elisa Coassin, Laura Veneroni, Michela Casanova, Maura Massimino, Andrea Ferrari Tumori, 2017
The challenge of very rare childhood cancers in developed and developing countries Andrea Ferrari, Dominik T. Schneider, Gianni Bisogno, Daniel Orbach, Milena Villarroel, Veronica Giron, Carlos Rodriguez-Galindo, Silvia Sorbara, Chiara Magni, Stefano Chiaravalli, Michela Casanova, Giovanni Cecchetto, Jan Godzinski, Ewa Bien, Teresa Stachowicz-Stencel, Bernadette Brennan, Yves Reguerre, Iyad Sultan, Ines B. Brecht Expert Opinion on Orphan Drugs, 2017
Extraskeletal osteosarcoma: A European Musculoskeletal Oncology Society study on 266 patients A. Longhi, S.S. Bielack, R. Grimer, J. Whelan, R. Windhager, A. Leithner, A. Gronchi, D. Biau, P. Jutte, A.H. Krieg, F.M. Klenke, G. Grignani, D.M. Donati, R. Capanna, J. Casanova, C. Gerrand, G. Bisogno, S. Hecker-Nolting, M. De Lisa, L. D'Ambrosio, M. Willegger, G. Scoccianti, S. Ferrari European Journal of Cancer, 2017
Mature and immature teratoma: A report from the second Italian pediatric study Monica Terenziani, Paolo D'Angelo, Alessandro Inserra, Renata Boldrini, Gianni Bisogno, Gian Luca Babbo, Massimo Conte, Patrizia Dall' Igna, Maria Debora De Pasquale, Paolo Indolfi, Luigi Piva, Giovanna Riccipetitoni, Fortunato Siracusa, Filippo Spreafico, Paolo Tamaro, Giovanni Cecchetto Pediatric Blood and Cancer, 2015
Appendiceal neuroendocrine tumours in childhood: Italian TREP project Calogero Virgone, Giovanni Cecchetto, Rita Alaggio, Andrea Ferrari, Gianni Bisogno, Massimo Conte, Alessandro Inserra, Anna M. Fagnani, Paolo Indolfi, Nunzio Salfi, Patrizia Dall'Igna Journal of Pediatric Gastroenterology and Nutrition, 2014
Long-term prognosis of patients with pediatric pheochromocytoma Birke Bausch, Ulrich Wellner, Dirk Bausch, Francesca Schiavi, Marta Barontini, Gabriela Sanso, Martin K Walz, Mariola Peczkowska, Georges Weryha, Patrizia Dall'Igna, Giovanni Cecchetto, Gianni Bisogno, Lars C Moeller, Detlef Bockenhauer, Attila Patocs, Karoly Rácz, Dmitry Zabolotnyi, Svetlana Yaremchuk, Iveta Dzivite-Krisane, Frederic Castinetti, David Taieb, Angelica Malinoc, Ernst von Dobschuetz, Jochen Roessler, Kurt W Schmid, Giuseppe Opocher, Charis Eng, Hartmut P H Neumann Endocrine Related Cancer, 2014
Synchronous bilateral Wilms tumor: A report from the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) Paolo Indolfi, Alessandro Jenkner, Monica Terenziani, Alessandro Crocoli, Annalisa Serra, Paola Collini, Davide Biasoni, Lorenza Gandola, Gianni Bisogno, Giovanni Cecchetto, Martina Di Martino, Paolo D'Angelo, Maurizio Bianchi, Massimo Conte, Alessandro Inserra, Andrea Pession, Filippo Spreafico, on behalf of the AIEOP Wilms Tumor Working Group Cancer, 2013
Fibroblastic tumors of intermediate malignancy in childhood Andrea Ferrari, Rita Alaggio, Cristina Meazza, Stefano Chiaravalli, Marco Vajna de Pava, Michela Casanova, Elena Cavaliere, Gianni Bisogno Expert Review of Anticancer Therapy, 2013
Ewing Sarcoma of the Bone in Children under 6 Years of Age Maria Antonietta De Ioris, Arcangelo Prete, Raffaele Cozza, Marta Podda, Carla Manzitti, Andrea Pession, Elisabetta Schiavello, Benedetta Contoli, Rita Balter, Franca Fagioli, Gianni Bisogno, Loredana Amoroso, Franco Locatelli, Roberto Luksch Plos One, 2013
Metastatic renal cell carcinoma in children and adolescents: A 30-year unsuccessful story Paolo Indolfi, Filippo Spreafico, Paola Collini, Giovanni Cecchetto, Fiorina Casale, Monica Terenziani, Amalia Schiavetti, Paolo Pierani, Luigi Piva, Daniela Cuzzubbo, Maria D. De Pasquale, Elvira Pota, Alessandro Inserra, Gianni Bisogno Journal of Pediatric Hematology Oncology, 2012
Primary renal soft tissue sarcoma in children Arianna Tagarelli, Filippo Spreafico, Andrea Ferrari, Rita Alaggio, Giovanni Cecchetto, Paola Collini, Paolo Indolfi, Roberta Burnelli, Laura Morali, Gianni Bisogno Urology, 2012
Neonatal soft tissue sarcomas Andrea Ferrari, Daniel Orbach, Iyad Sultan, Michela Casanova, Gianni Bisogno Seminars in Fetal and Neonatal Medicine, 2012
Embryonal cancers in Europe Gemma Gatta, Andrea Ferrari, Charles A. Stiller, Guido Pastore, Gianni Bisogno, Annalisa Trama, Riccardo Capocaccia European Journal of Cancer, 2012
Very rare tumours in paediatric age - From 'Tumori Rari in Età Pediatrica' to the European cooperative study group for paediatric rare tumours Gianni Bisogno, Giovanni Cecchetto, Andrea Ferrari, Paediatric Consultant, Head, Solid Tumour Unit, Haematology/Oncology Division, Department of Paediatrics, University Hospital of Padua, Associate Professor, Division of Paediatric Surgery, Department of Paediatrics, University Hospital of Padua, Oncologist Consultant, Head, Outpatient Service, Paediatric Oncology Unit, National Tumour Institute, IRCCS, Milan, Italy European Oncology and Haematology, 2012
Foreign children with cancer in Italy Roberto Rondelli, Giorgio Dini, Marisa De Rosa, Paola Quarello, Gianni Bisogno, Maurizio Aricò, Carivaldo Vasconcelos, Paolo Tamaro, Gabriella Casazza, Marco Zecca, Clementina De Laurentis, Fulvio Porta, Andrea Pession Italian Journal of Pediatrics, 2011
Effect of eradication of Helicobacter pylori in children with chronic immune thrombocytopenia: A prospective, controlled, multicenter study Giovanna Russo, Vito Miraglia, Francesca Branciforte, Sofia Maria Rosaria Matarese, Marco Zecca, Gianni Bisogno, Emilia Parodi, Giovanni Amendola, Paola Giordano, Momcilo Jankovic, Annalisa Corti, Margherita Nardi, Piero Farruggia, Laura Battisti, Carlo Baronci, Giovanni Palazzi, Fabio Tucci, Stefania Ceppi, Bruno Nobili, Ugo Ramenghi, Domenico De Mattia, Lucia Notarangelo, the AIEOP‐ITP Study Group Pediatric Blood and Cancer, 2011
Pancreatic tumors in children and adolescents: The Italian TREP project experience Patrizia Dall'Igna, Giovanni Cecchetto, Gianni Bisogno, Massimo Conte, Pierluigi Lelli Chiesa, Paolo D'Angelo, Francesco De Leonardis, Gianluca De Salvo, Francesca Favini, Andrea Ferrari, on Behalf of the TREP Group Pediatric Blood and Cancer, 2010
Synovial sarcoma of children and adolescents: The prognostic role of axial sites Andrea Ferrari, Gianni Bisogno, Rita Alaggio, Giovanni Cecchetto, Paola Collini, Angelo Rosolen, Cristina Meazza, Paolo Indolfi, Alberto Garaventa, Luigi De Sio, Paolo D’Angelo, Paolo Tamaro, Michela Casanova, Modesto Carli European Journal of Cancer, 2008
Prognostic factors in pleura-pulmonary blastoma Paolo Indolfi, Gianni Bisogno, Fiorina Casale, Giovanni Cecchetto, Gianluca De Salvo, Andrea Ferrari, Alberto Donfrancesco, Vittoria Donofrio, Antonio Martone, Martina Di Martino, Maria T. Di Tullio Pediatric Blood and Cancer, 2007
Initial surgery for localized rhabdomyosarcoma: A report from the Italian Soft Tissue Sarcoma Cooperative Group studies Italian Journal of Pediatrics, 2005
Secondary leiomyosarcomas: A report of 4 cases Gianni Bisogno, Monica Spiller, Giovanni Scarzello, Giovanni Cecchetto, Maurizio Mascarin, Paolo Indolfi, A. Ferrari, Modesto Carli Pediatric Hematology and Oncology, 2005
Teratoid Wilms' tumor: Report of a unilateral case Giovanni Cecchetto, Rita Alaggio, Giovanni Scarzello, Patrizia Dall'Igna, Ascanio Martino, Gianni Bisogno, Maurizio Guglielmi Journal of Pediatric Surgery, 2003
Renal cell carcinoma in children: A clinicopathologic study Paolo Indolfi, Monica Terenziani, Fiorina Casale, Modesto Carli, Gianni Bisogno, Amalia Schiavetti, Antonia Mancini, Roberto Rondelli, Andrea Pession, Alessandro Jenkner, Paolo Pierani, Paolo Tamaro, Bruno De Bernardi, Andrea Ferrari, Nicola Santoro, Maria Giuliano, Giovanni Cecchetto, Luigi Piva, Gianmarco Surico, M. Teresa Di Tullio Journal of Clinical Oncology, 2003
Role of mutilating surgery in the treatment of non-chemosensitive pediatric soft tissue sarcomas. Experience of the Italian Cooperative Group Studies RMS-79 and RMS-88 La Pediatria Medica E Chirurgica Medical and Surgical Pediatrics, 2003
Primary intracranial fibrosarcoma Gianni Bisogno, Jelena Roganovic, Modesto Carli, Giovanni Scarzello, Milena Calderone, Roberto Faggin, Giorgio Perilongo Child S Nervous System, 2002
Paratesticular rhabdomyosarcoma: A comparison of two Italian studies - A report from the Italian Cooperative Group for Pediatric Soft Tissue Sarcoma Italian Journal of Pediatrics, 2002
Vascular tumors in pediatric age. The experience of the Italian and German Cooperative Group Italian Journal of Pediatrics, 2001
Soft tissue sarcoma in childhood: local treatment in patients under 3 years of age. Analysis of the RMS-88 multicenter study La Pediatria Medica E Chirurgica Medical and Surgical Pediatrics, 2001
Undifferentiated (embryonal) sarcoma of the liver in childhood the experience of the Italian Cooperative croup on Pédiatrie Soft Tissue Sarcoma Rivista Italiana Di Pediatria, 2000
Malignant peripheral nerve sheath tumor in childhood. An experience of the Italian Cooperative Group on Soft Tissue Sarcoma Rivista Italiana Di Pediatria, 1997